Brief: Exact Therapeutics Says With FDA's Guidance, Co Will Now Focus On Enact Trial ,Stop Recruitment Into Activate Trial
06/08/2024 17:34
Aug 6 (Reuters) - Exact Therapeutics AS EXTX.OL :
* EXACT THERAPEUTICS - WITH FDA'S GUIDANCE, CO WILL NOW
FOCUS ON
ENACT TRIAL ,STOP RECRUITMENT INTO ACTIVATE TRIAL
Source text for Eikon: ID:nObiBz4lra
Further company coverage: EXTX.OL
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Exact Therapeutics AS
See all newsBrief: EXACT Therapeutics AS Gets Positive Safety Review For 60 Μl/Kg Dose In Phase 2 ENACT Trial
Brief: Exact Therapeutics Introduces New Long-Term Incentive Program
Brief: Exact Therapeutics H1 Operating Loss Widens To NOK 45.9 Million
Brief: Exact Therapeutics Announces Grant Of Core Patent In U.S.
Brief: Exact Therapeutics Announces Final Positive Data From Phase 1 Trial